A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

Trial Profile

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Nov 2017

At a glance

  • Drugs RO 7049389 (Primary) ; Midazolam
  • Indications Hepatitis B
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 07 Aug 2017 Planned End Date changed from 1 Aug 2018 to 25 Jan 2019.
    • 07 Aug 2017 Planned primary completion date changed from 1 Aug 2018 to 25 Jan 2019.
    • 07 Aug 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top